Quality of life in drug-resistant epilepsy: relationships with negative affectivity, memory, somatic symptoms and social support

Autores de IIS La Fe

• Kevin Gill Hampel

  Autor

• Mercedes Garcés Sánchez

  Autor

• Vicente Enrique Villanueva Haba

  Autor

Participantes ajenos a IIS La Fe

• Cano-Lopez, I
• Gonzalez-Bono, E

Abstract

Objective: To investigate the relative contribution of factors non-directly related to seizures such as negative affectivity, social support, somatic symptoms and memory performance on quality of life (QOL) in patients with drug-resistant epilepsy. Methods: This is a cross-sectional study. Seventy patients with drug-resistant epilepsy were consecutively recruited from the inpatient Epilepsy Unit, Hospital Universitario y Politecnico La Fe, between April 2015 and October 2017. Medical history provided demographic characteristics of the patients (sex, age, and educational level), and clinical data (age at epilepsy onset, duration of epilepsy in years, frequency of seizures per month, type of seizures and number of AEDs). Presurgical assessment included diagnosis of the type of epilepsy and the lateralization of the epileptogenic area. All the patients underwent a neuropsychological assessment in which QOL (QOLIE-31), negative affectivity, social support, somatic symptoms, and memory were evaluated. Results: Negative affectivity (including anxiety-trait and depression), social support, neurosensory symptoms, and long-term verbal memory were significantly related to QOL composite score (for all, p < .009), subscales of QOL showing different sensitivities to them. Even after controlling for negative affectivity, neurosensory symptoms and long-term verbal memory significantly contribute to QOL composite score (p = .0001). Conclusion: Results suggest that clinical management of patients with drug-resistant epilepsy should consider the treatment of verbal memory impairments at an early stage. Recognition of negative affectivity, poor social support and high somatic symptoms would also lead health professionals to develop different strategies to improve the QOL of patients with drug-resistant epilepsy.

Keywords

• TEMPORAL-LOBE EPILEPSY; PHARMACORESISTANT EPILEPSY; DEPRESSION; ANXIETY; INVENTORY; PEOPLE; COMORBIDITIES; DETERMINANTS; ASSOCIATION; HANDEDNESS